51. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome
- Author
-
Clarisa Brezzo, Marcela Perez, Diego Cecchini, Susana Poggi, M Ambroggi, Marcelo Corti, Juan Ambrosioni, and Ana Rybko
- Subjects
Adult ,Male ,medicine.medical_specialty ,Tuberculosis ,Immunology ,Population ,Antitubercular Agents ,Drug resistance ,Tuberculous meningitis ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,Tuberculosis, Multidrug-Resistant ,medicine ,Immunology and Allergy ,Humans ,education ,Retrospective Studies ,education.field_of_study ,AIDS-Related Opportunistic Infections ,business.industry ,Retrospective cohort study ,medicine.disease ,Prognosis ,Surgery ,Infectious Diseases ,Clinical research ,Treatment Outcome ,Tuberculosis, Meningeal ,Female ,business ,Meningitis - Abstract
The objective of this study was to identify prognostic factors of death in patients with tuberculous meningitis (TM) and show the impact of infection by multidrug-resistant strains on the outcome of this disease. We retrospectively analysed clinical charts of HIV-infected patients with culture-confirmed TM attending our institution during 1996-2004. The following variables were associated with death during hospitalization: neurological signs at admission, a CD4 T-cell count less than 50 cells/microl and infection by multidrug-resistant strains.
- Published
- 2007